[EN] HETEROARYL COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS HÉTÉROARYLE ET LEURS UTILISATIONS
申请人:AVILA THERAPEUTICS INC
公开号:WO2012061303A1
公开(公告)日:2012-05-10
Heterocyclic pynmidine compounds that modulate mutant-selective epidermal growth factor receptor (EGFR) kinase activity are disclosed. Selectivity in modulation of various EGFR mutant activity has been disclosed. Pharmaceutical compositions comprising the pynmidine derivative, and methods of treatment for diseases associated with EGFR kinase activity including non-small cell lung cancer comprising administration of the pynmidine derivative are disclosed.